Skip to main content
Clinical Trials/NCT04215276
NCT04215276CompletedNot Applicable

Comparison of Valsalva Maneuver and Control in Reducing Pain During Spinal Injection

Indonesia University2 sites in 1 country70 target enrollmentStarted: January 21, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
70
Locations
2
Primary Endpoint
Pain measurement during injection with VAS score

Study Overview

Brief Summary

The study aimed to compare the effectiveness of Valsalva maneuver as non pharmacological approach and control in reducing pain during spinal injection.

Detailed Description

This was an experimental study on 70 subjects with 35 subjects treated with Valsalva maneuver and 35 subjects treated as control from January to April 2019. Research subjects were female who underwent brachytherapy for the first time with spinal anesthesia. The effectiveness in reducing pain was assessed by using Visual Analogue Scale (VAS) and patient movement during the surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients underwent elective surgery using spinal anesthesia
  • patients who have not undergone spinal anesthesia before
  • Physical status ASA I or II
  • Signing informed consent

Exclusion Criteria

  • have a spinal anesthesia history
  • contraindicated for spinal anesthesia
  • subjects who cannot do Valsalva to 30mmHg pressure for 20 seconds
  • have a allergic history to local anesthetics or opioid drugs

Outcomes

Primary Outcomes

Pain measurement during injection with VAS score

Time Frame: 30 seconds

Pain degree was measured with VAS score \[0 equals to no pain whereas 10 equals to the maximum pain\]

Secondary Outcomes

  • Patient movement(30 seconds)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alfan Mahdi Nugroho

Principal Investigator

Indonesia University

Study Sites (2)

Loading locations...

Similar Trials